Top 10 Life Science Angel Investors in Spain in May 2026
Top 10 Life Science Angel Investors in Spain in May 2026
| Investor | Life Science Spain investments |
|---|---|
| Mariliis Holm | 1 |
| Inaki Berenguer | 1 |
| David Brandes | 1 |
| Arnaldo Marziali | 1 |
| Milad Alucozai | 1 |
| Arman Anatürk | 1 |
| Arturo Elizondo | 1 |
| Ryan Bethencourt | 1 |
| John Bethell | 1 |
| Ritu Bansal-Mutalik | 1 |
Reach every investor
Get a list of investors who already back your industry, stage, and country. Emails & phones included.
Find investors — It's Free!I am a food scientist, entrepreneur and investor. Through SFV (sustainablefoodventures.com), I back founders building the future of cell-based, plant-based and recombinant food.
Show more...Investment focus
- Food Processing, Seafood, Wellness
- Pre-Seed, Angel
- Spain, Iceland, United States
Portfolio highlights
- Loki Foods — We're producing sustainable, plant-based foods from the Arctic. Iceland’s first plant-based cod and seafood!
- Sobo Foods — Sobo Foods is a plant based comfort food provider.
- Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
Inaki Berenguer is the President and Co-founder at iPronics Programmable Photonics.
Show more...Investment focus
- FinTech, E-Commerce, Financial Services
- Seed, Angel, Pre-Seed
- Spain, United States, United Kingdom
Portfolio highlights
- Ukio — Artfully designed fully furnished apartments available for extended stays
- Paack — Online sales growth and customer satisfaction are hampered by inadequate delivery experiences. Existing last mile delivery companies are incapable of providing a truly customer-centric approach. Our proprietary technology stack and operational excellence is built specifically to service time slot deliveries, controlled entirely by the endcustomer. This creates unprecedented results through basket conversion, loyalty, repeat purchase, acquisition, brand image and customer satisfaction, plus they can actually help the environment.Paack operates in Europe (UK, France, Spain and Portugal).
- Openlytics — Openlytics is a visual analytics platform. It allows Data Workers to create pipelines for data transformation and analysis, in a visual way. Our mission is to empower everyone in the organization to solve data problems, without waiting for developers.Openlytics is an early-stage company, looking to build a founding team that can shape thedirection of the product. We’re seed-funded, remote-first, and hiring.If you're interested in learning more, email us at hello@openlytics.io.
David Brandes - Managing Director & Co-Founder @ Peace of Meat
Show more...Investment focus
- Wellness, Life Science, Biotechnology
- Seed
- Spain
Portfolio highlights
- Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
Arnaldo Marziali
Show more...Investment focus
- Big Data, Software, Life Science
- Pre-Seed
- Spain
Portfolio highlights
- Seqera — Seqera Labs is a Barcelona-based business creating solutions for high-performance computing workloads across cloud and clusters. It was founded by the creators of the popular open-source workflow software Nextflow (http://www.nextflow.io).
Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University.
Show more...Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A, Pre-Seed
- United States, Canada, United Kingdom
Portfolio highlights
- Replit — Replit is a simple yet powerful online IDE, Editor, Compiler, Interpreter, and REPL. Code, compile, run, and host in 50+ programming languages.
- Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
- Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
Arman Anatürk is Co-Founder @ FoodHack.
Show more...Investment focus
- Biotechnology, Food and Beverage, Wellness
- Seed, Pre-Seed
- Spain, Israel, Germany
Portfolio highlights
- Bosque Foods — Kinoko Labs develops the next generation of meat substitutes, starting with whole-cut meat items made from fungal mycelium produced organically. Headquartered in New York.
- Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
- Kynda — Keen 4 Greens offers a wide range of vegan products. Founded in 2019, Keen 4 Greens is based in Hamburg, Germany.
Arturo Elizondo is CEO of Clara Foods, a sustainable ingredients company making the world’s most comprehensive egg white substitute. Clara leverages advances in fermentation technology to bring an egg white to the table that is completely animal-free, far more sustainable, and free of salmonella without compromising the qualities we know and love.Prior to joining Clara Foods, Arturo worked at the investment bank Credit Suisse, U.S. Department of Agriculture, and under Supreme Court Justice Sonia Sotomayor.
Show more...Investment focus
- Wellness, Life Science, Biotechnology
- Seed, Pre-Seed
- Spain, Switzerland
Portfolio highlights
- Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
- Cultivated Biosciences — Cultivated - Creamy, dairy-free indulgence
Ryan is a co-founder and CEO at Wild Earth and a co-founder and Partner at Sustainable Food Ventures, bringing years of experience in leading, building and advising high-growth food and biotechnology companies. Ryan is a biotech entrepreneur, investor, and one of the founders of the biohacker movement. He’s a co-founder and former Program Directorat IndieBio and has invested in over 130 early stage biotech startups and served as the head of life sciences at the XPRIZE Foundation. As an ethical vegan, Ryan is passionate about the future of biology as a technology, applied across all industries to solve some of humanity’s most intractable problems. Ryan fosters dogs for Rocket Dog Rescue and is passionate about mindfulness, meditation, and mentoring. His work at the interface of science, food, and business has been covered by many major publications.
Show more...Investment focus
- Biotechnology, Food Processing, Food and Beverage
- Pre-Seed, Seed, Angel
- United States, Chile, India
Portfolio highlights
- Evo Foods — EVO foods is creating India’s first 100% plant based liquid egg
- WTH Foods — WTH Foods is a plant-based alternative protein company based in Manila, Philippines. Using local and sustainable ingredients, we create plant-based versions of processed meat products that Southeast Asian love
- Arcturus BioCloud — Arcturus delivers granular insights, climate metrics and sustainability risks on the drivers of climate and ESG profiles for investment holdings via a climate and Sustainability Intelligence SaaS.
Originally studying medicine in Scotland, John is a pioneer of the Australasian medical recruitment industry and has over 20 years of experience growing his award-winning business, Wavelength International, from two founders to over 100 staff. Moving to Europe in 2012, John worked initially for an equity crowdfunding business focused on raisingseed funds for European life sciences start-ups, before launching the Luka Global Group, including LUKA BIO, with the co-founders in 2019. John provides guidance and mentorship to start-up founders on how to set up their own in-house recruitment capabilities in preparation for growth. His recruitment portfolio includes C-suite, medical and research roles within life sciences.
Show more...Investment focus
- FinTech, Medical, Life Science
- Debt Financing
- Spain
Portfolio highlights
- Capital Cell — Capital Cell is a crowdinvesting platform for biotech and life sciences companies. Mixing VC, business angels, accredited investors, and the power of the crowd, the company is building a global meeting point for companies and researchers working, fostering, and financing tomorrow’s medical science.
Ritu Bansal-Mutalik is a Senior Director, Process Research and Development at ZymoChem.
Show more...Investment focus
- Wellness, Life Science, Biotechnology
- Seed
- Spain
Portfolio highlights
- Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
Contact investors today
Find who invests in your industry, stage, and country in 5 minutes.
Find investors — It's Free!